TRIM27 antibody (full length)
Quick Overview for TRIM27 antibody (full length) (ABIN7879208)
Target
See all TRIM27 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- TRIM27 Antibody
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human TRIM27 protein was used as the immunogen for the TRIM27 antibody.
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal dilution of the TRIM27 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the TRIM27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TRIM27 (Tripartite Motif Containing 27 (TRIM27))
-
Alternative Name
- TRIM27
-
Background
- Defects in TRIM27 are a cause of thyroid papillary carcinoma (TPC). TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells.
-
UniProt
- P14373
Target
-